American International Group, Inc. Neuro Bo Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.74 - $4.63 $10,757 - $18,177	-3,926 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$3.93 - $6.68 $5,651 - $9,605	1,438 Added 57.8%	3,926 $17,000
Q4 2020 Feb 12, 2021	SELL	$5.02 - $6.59 $356 - $467	-71 Reduced 2.77%	2,488 $13,000
Q3 2020 Nov 04, 2020	SELL	$5.41 - $8.67 $319 - $511	-59 Reduced 2.25%	2,559 $14,000
Q2 2020 Aug 12, 2020	BUY	$8.05 - $29.44 $21,074 - $77,073	2,618 New	2,618 $21,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.